You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Geostatistical Software for Non-Parametric Geostatistical Modeling of Uncertainty
SBC: BIO-ANALYTICS, INC. Topic: NLM7. Project Summary/Abstract A key component in any investigation of association and/or cause-effect relationships between the environment and health outcomes is the availability of accurate and precise models of exposure. Because the cost of collecting field data is often prohibitive, it is critical to incorporate any source of secondary information available to supplement sparse datasets. Seconda ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders
SBC: INNATEVR LLC Topic: NIDAPROJECT SUMMARY Opioid and/or Stimulant Use Disorders (OUD/StUD) are chronic, recurring conditions that if left untreated, pose a significant and ongoing public health and safety threat, with costs associated with OUD alone in the US exceeding one trillion dollars annually. Virtual Reality Cue Exposure (VRCE) employs safe and controlled repeated exposure to a variety of substance use cues and envi ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Multisensory Augmented Reality as a bridge to audio-only accommodations for inclusive STEM interactive digital media
SBC: ALCHEMIE SOLUTIONS, INC. Topic: 500Only 3% of individuals who are blind or have low vision (BLV) have been employed in a STEM field. The lack of accessible accommodations to visually rich dynamic STEM content creates roadblocks to success for BLV students in STEM education throughout their academic journey. The goal of this SBIR is a usable system of accommodations for Interactive Digital Media (IDM), so students with profound visu ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophy
SBC: STRYKAGEN CORPORATION Topic: 100Abstract Duchenne Muscular Dystrophy (DMD) is a fatal muscle disease with an incidence of 1 in 5000 males. DMD results from mutations in the gene encoding dystrophin, a 427 kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and laminin in the extracellular matrix. The α7β1 integrin is a transmembrane linkage system in skeletal and card ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot
SBC: LITTLE ROOM INNOVATIONS LLC Topic: NICHDPROJECT SUMMARYWhile conventional wisdom holds that individuals with longer residual limbs retain greater function, they are actually confined to low-profile feet that limit performance. In particular, low-profile feet are often much stiffer than their standard profile counterparts. As such, many of the individuals with transtibial amputation that have long residual limbs are unable to obtain pros ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
A novel platform for synthetic generation and statistical obfuscation of tabular clinical data, simulated images, and machine-generated text
SBC: GRAYRAIN, LLC Topic: NCATSPROJECT SUMMARY Data is a critical and highly valuable commodity, driving meaningful change in our society, especially when it pertains to patient care and biomedical research. Currently, institutions pay inordinate sums to increase, regain, and complement their data panels. As an extra burden, data legislation and privacy protection regulations introduce barriers to forming effective partnerships ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Genome Editing Therapy for Usher Syndrome Type 3
SBC: GENETOBE INC Topic: NEIPROJECT SUMMARY/ABSTRACTUsher syndrome type 3A (USH3A), an autosomal recessive disorder, is characterized by progressive loss of hearing and vision due to a clarin-1 (CLRN1) gene mutation. A person with type 3 Usher syndrome will usually require cochlea implants by mid- to late adulthood and classified as being legally blind. The management of the chronic, progressive, severe vision loss (retiniti ...
STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu
SBC: TSRL, INC. Topic: NIAIDAbstract Yearly influenza epidemics strike millions of people, causing up to 500,000 deaths. Fatality caused by most seasonal influenza viruses is lt0.03%, but with significant mortality in the young and the elderly populations. When a new pathogenic influenza strain enters the population, a pandemic could kill tens of millions of people with a negative economic impact estimated to be over 150 bil ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
A web-based platform for robust single-cell analysis, bulk data deconvolution and system-level analysis
SBC: ADVAITA CORP Topic: 400PROJECT SUMMARY Together with the ability to measure genome-wide expression of millions of individual cells, single-cell technologies have also brought the challenge of translating such data into a better understanding of the underlying biological phenomena. Existing computational methods and software for single-cell data analysis have critical limitations related to scalability, accuracy, usabili ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy
SBC: Pure Green Pharmaceuticals Topic: 200PROJECT SUMMARY/ABSTRACT Painful diabetic peripheral neuropathy (pDPN) is a severe and debilitating nerve dysfunction prevalent in over 30 million US diabetic patients. It adversely affects patients by causing sensory pain in the lower limbs, muscular weakness, predisposition to falls, decreased quality of life, and significant patient morbidity as a result of foot ulcerations, amputations, and di ...
SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health